|
Volumn 12, Issue 10, 2001, Pages 1251-1263
|
Cross-strain protection against clinical and laboratory strains of Pseudomonas aeruginosa mediated by dendritic cells genetically modified to express CD40 ligand and pulsed with specific strains of Pseudomonas aeruginosa
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CROSS REACTING ANTIBODY;
GLYCOPROTEIN GP 39;
IMMUNOGLOBULIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBODY PRODUCTION;
ANTIBODY RESPONSE;
ARTICLE;
BACTERIUM ISOLATION;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DENDRITIC CELL;
DNA MODIFICATION;
ESCHERICHIA COLI;
FEMALE;
GENE EXPRESSION;
GENE THERAPY;
GENETIC ENGINEERING;
GRAM NEGATIVE INFECTION;
HUMORAL IMMUNITY;
IMMUNOGLOBULIN BLOOD LEVEL;
MOUSE;
NONHUMAN;
PSEUDOMONAS AERUGINOSA;
STRAIN DIFFERENCE;
ADENOVIRIDAE;
ANIMALS;
BONE MARROW CELLS;
CD4-POSITIVE T-LYMPHOCYTES;
CD40 LIGAND;
DENDRITIC CELLS;
FEMALE;
HUMANS;
IMMUNOGLOBULINS;
MICE;
MICE, INBRED C57BL;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
TIME FACTORS;
VACCINES, DNA;
ADENOVIRIDAE;
ANIMALIA;
BACTERIA (MICROORGANISMS);
ESCHERICHIA COLI;
NEGIBACTERIA;
PSEUDOMONAS;
PSEUDOMONAS AERUGINOSA;
|
EID: 0034920466
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/104303401750270913 Document Type: Article |
Times cited : (11)
|
References (35)
|